Quality of Care for Acute Coronary Syndrome Patients With Known Atherosclerotic Disease
- 18 August 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 120 (7) , 560-567
Abstract
Background— Patients with prior atherosclerosis in 1 or more vascular territories (coronary, cerebrovascular, or peripheral arterial) who present with acute coronary syndromes have high cardiovascular risk and may benefit significantly from evidence-based therapies, yet whether these are used consistently is unknown. Methods and Results— The Get With the Guidelines–Coronary Artery Disease database was queried to determine whether compliance with quality-of-care treatments for acute coronary syndrome patients was associated with the extent of prior vascular disease. A total of 143 999 patients enrolled at 438 sites between January 2000 and January 2008 were classified according to the absence (n=98 136; 68%) or presence of known preexistent atherosclerosis (before admission) in 1, 2, or 3 vascular territories (n=37 633 [26%], n=7369 [5%], and n=861 [0.6%], respectively). Overall in-hospital mortality was 5.3%, and mean length of stay was 5.6±6.7 days. Compared with patients without prior vascular disease, patients with prior vascular disease were older and had more comorbidities. They were less likely to undergo coronary revascularization and had longer duration of hospital stay and higher in-hospital mortality. After adjustment for clinical and hospital characteristics, compared with patients without prior vascular disease, patients with prior vascular disease had higher mortality and were less likely to receive 3 particular treatments (lipid-lowering therapy, smoking cessation counseling, and angiotensin-converting enzyme inhibitor for left ventricular dysfunction). Conclusions— Compared with acute coronary syndrome patients without prior vascular disease, those with prior atherosclerosis had higher in-hospital mortality yet were paradoxically less likely to receive specific evidence-based acute coronary syndrome treatments, which can form the basis for targeted intervention.Keywords
This publication has 20 references indexed in Scilit:
- Impact of Prior Peripheral Arterial Disease and Stroke on Outcomes of Acute Coronary Syndromes and Effect of Evidence-Based Therapies (from the Global Registry of Acute Coronary Events)The American Journal of Cardiology, 2007
- Treatment practices and outcomes of patients with established peripheral arterial disease hospitalized with acute myocardial infarction in a community settingAmerican Heart Journal, 2007
- Low ankle–brachial index predicts an adverse 1‐year outcome after acute coronary and cerebrovascular eventsJournal of Thrombosis and Haemostasis, 2006
- Association of peripheral artery disease with treatment and outcomes in acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE)American Heart Journal, 2006
- Usefulness of the Presence of Peripheral Vascular Disease in Predicting Mortality in Acute Myocardial Infarction Patients Treated With Primary Angioplasty (from the Primary Angioplasty in Myocardial Infarction Database)The American Journal of Cardiology, 2005
- Get With the Guidelines for Cardiovascular Secondary PreventionArchives of internal medicine (1960), 2004
- Using “Get With The Guidelines” to Improve Cardiovascular Secondary PreventionThe Joint Commission Journal on Quality and Safety, 2003
- Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: Are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 studyAmerican Heart Journal, 2003
- Association of Carotid Artery Intima-Media Thickness with Complex Aortic Atherosclerosis in Patients with Recent StrokeAngiology, 2002
- Evidence of a chronic systemic cause of instability of atherosclerotic plaquesThe Lancet, 2000